Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.020
-0.010 (-0.97%)
At close: May 11, 2026, 4:00 PM EDT
1.040
+0.020 (1.96%)
After-hours: May 11, 2026, 7:46 PM EDT
Lucid Diagnostics Revenue
In the year 2025, Lucid Diagnostics had annual revenue of $4.71M with 8.28% growth. Lucid Diagnostics had revenue of $1.50M in the quarter ending December 31, 2025, with 25.65% growth.
Revenue (ttm)
$4.71M
Revenue Growth
+8.28%
P/S Ratio
40.89
Revenue / Employee
$57,390
Employees
82
Market Cap
192.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.71M | 360.00K | 8.28% |
| Dec 31, 2024 | 4.35M | 1.92M | 79.00% |
| Dec 31, 2023 | 2.43M | 2.05M | 544.03% |
| Dec 31, 2022 | 377.00K | -123.00K | -24.60% |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 351.50M |
| InfuSystem Holdings | 142.40M |
| RxSight | 127.48M |
| Owlet | 105.71M |
| Electromed | 68.86M |
| CVRx, Inc. | 56.65M |
| Apyx Medical | 52.84M |
| Senseonics Holdings | 40.71M |
LUCD News
- 10 days ago - PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 - PRNewsWire
- 11 days ago - Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - PRNewsWire
- 17 days ago - Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - PRNewsWire
- 18 days ago - Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering - TheFly
- 18 days ago - Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - PRNewsWire
- 4 weeks ago - Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 4 weeks ago - Lucid Diagnostics price target raised to $9 from $8.25 at Ascendiant - TheFly
- 5 weeks ago - PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio - PRNewsWire